PUBLISHER: Grand View Research | PRODUCT CODE: 1097029
PUBLISHER: Grand View Research | PRODUCT CODE: 1097029
The global home dialysis systems market is anticipated to reach USD 42.32 billion by 2030, growing at a CAGR of 10.34% % over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow due to the increasing prevalence of Acute Kidney Injury (AKI), and increasing demand for remote patient management platforms.
Moreover, technological advancements along with an increasing number of agreements between prominent players will drive market growth in the near future. For instance, in May 2021, Baxter SAS and Physidia launched a co-promotion agreement in France to promote dialysis patients' homecare. The goal of this collaboration is to allow patients who are transitioning from peritoneal dialysis to get frequent hemodialysis at home utilizing Physidia's S3 device. This, in turn, is anticipated to boost the market growth in the near future.
The current COVID-19 outbreak is expected to have a positive impact on the home dialysis systems market. While rising healthcare costs and increasing disease burden in the U.S have already contributed to a boost in care at home services. According to Fresenius Medical Care, home hemodialysis rose 41% in North America in the second quarter. As a result of this, the market is expected to grow in near future.
Furthermore, rising medical requirements resulting from the aging population, increased demand for novel products and therapies, and developments in medical technology are all likely to contribute to market growth after COVID-19. Increasing initiatives by public and private groups to encourage home HD/PD may generate further economic opportunities for the industry after COVID-19.